Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Juno Pharmaceuticals Pty. Ltd.

www.junopharm.au

Latest From Juno Pharmaceuticals Pty. Ltd.

Asia Deal Watch: ASLAN, Bukwang Establish Immuno-Oncology JV In Singapore

The JV to be called JAGUAHR Therapeutics will focus on the AhR pathway. Simcere acquires Chinese rights to JW’s gout candidate.

Deals Business Strategies

Juno And Celltrion Partner For Australian Biosimilars Push

Australia’s Juno Pharmaceuticals has struck a deal with Korea’s Celltrion to partner on marketing biosimilar trastuzumab and rituximab.

Deals Strategy

Australian Advisors Will Ponder Sandoz’ Pegfilgrastim And Pfizer’s Trastuzumab

A body that advises Australia’s Department of Health on reimbursement will in November consider listing applications for Sandoz’ Ziextenzo pegfilgrastim candidate and well as for Pfizer’s recently authorized Trazimera trastuzumab brand.

Australia Biosimilars

Cell Therapy Firms Advised To Complete Major CMC Changes Before Pivotal Trials

The sooner CAR-T therapy developers ask their regulatory questions and make their CMC changes, the better, industry official says.

Manufacturing Quality
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Poison (Antidote)
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Juno Pharmaceuticals Pty. Ltd.
  • Senior Management
  • George Katsanos, CEO
    Paul Meulblok, CFO & Chief Information Officer
  • Contact Info
  • Juno Pharmaceuticals Pty. Ltd.
    Phone: 3 8888 1288
    Level 2, 6 Bond St.
    South Yarra, 3141
    Australia
UsernamePublicRestriction

Register